Diabetic Peripheral Neuropathy

diabetic peripheral neuropathy

Underlying Cause of Diabetic Peripheral Neuropathy Targeted in Gene Therapy Trial

VM BioPharma, the United States division of ViroMed Co., Ltd. in Seoul, Korea, announced the first patient was dosed in the recently initiated Phase 3 clinical study evaluating VM202, a proprietary DNA-based biopharmaceutical, in patients with painful diabetic peripheral neuropathy (DPN). This is the first pivotal gene therapy trial specifically targeting the most common cause …

Underlying Cause of Diabetic Peripheral Neuropathy Targeted in Gene Therapy Trial Read More »

Small Nerve Fibers Defy Neuropathy Conventions

Peripheral neuropathy research study suggests even prediabetes could cause nerve damage. Peripheral neuropathy research results of a small study of people with tingling pain in their hands and feet have added to evidence that so-called prediabetes is more damaging to motor nerves than once believed. The report on the study was published online in JAMA …

Small Nerve Fibers Defy Neuropathy Conventions Read More »

FPN Connects Peripheral Neuropathy Researchers at Astellas Pharma to the Patients They Are Hoping to Serve

On December 3, 2015, Astellas Pharma US, Inc. (the U.S. affiliate of Astellas Pharma Inc.), a R&D-driven global pharmaceutical company, invited the Foundation for Peripheral Neuropathy to present to a global team working on development of ASP3662 for patients with neuropathic pain (NP). This was an internal meeting, which included Ulf Tollemar, Executive Director, Development …

FPN Connects Peripheral Neuropathy Researchers at Astellas Pharma to the Patients They Are Hoping to Serve Read More »

New Findings Point to Central Nervous System Role in Painful Diabetic Peripheral Neuropathy

Emerging evidence suggests that the central nervous system (CNS) is a key contributor to the problem of painful peripheral nerve disease in people with diabetes, according to a special article in the February issue of Pain, the official publication of the International Association for the Study of Pain (IASP).  READ MORE Source: MedicalPress

Study Reports Peripheral Neuropathy is Associated with Mitochondrial Dysfunction

A new study led by researchers at McGill University in Canada recently revealed that peripheral neuropathy is associated with a mitochondrial dysfunction and a bioenergetic impairment. Mitochondria are small cellular organelles in the body responsible for the production of energy through the process of respiration. Mitochondria dysfunction can impair the cellular energy metabolism, affecting several …

Study Reports Peripheral Neuropathy is Associated with Mitochondrial Dysfunction Read More »

Stem Cells Show Promise as Treatment for Diabetic Neuropathy

Research released earlier this summer shows that rats who received intra-muscular injections of mesenchymal stem cells (MSC’s are adult stem cells traditionally found in the bone marrow. but can also be isolated from other tissues including cord blood, peripheral blood, fallopian tube, and fetal liver and lung) 12 weeks after the induction of diabetes offered …

Stem Cells Show Promise as Treatment for Diabetic Neuropathy Read More »

Efficacy and Safety of Qutenzatm (8% Capsaicin Patch)

Neuropathy is one of the most common long-term complications of diabetes mellitus (DM) and painful neuropathy can be challenging to treat. There is no consensus on optimal treatment and many current therapies are limited by their tolerability, the need for titration, drug-drug interactions, administration of multiple daily doses, or the invasive nature of surgical procedures …

Efficacy and Safety of Qutenzatm (8% Capsaicin Patch) Read More »

lab researcher working with lab equipment

New Study Shows Tapentadol Extended Release May Significantly Reduce Average Pain for Diabetic Peripheral Neuropathy

With more than 26 million people in the US living with diabetes, as reported by the Centers for Disease Control, approximately 60-70% of them will develop nerve damage called neuropathy at some point. New research has been published indicating that patients suffering with diabetic peripheral neuropathy (DPN) may experience a significant improvement in their pain …

New Study Shows Tapentadol Extended Release May Significantly Reduce Average Pain for Diabetic Peripheral Neuropathy Read More »

Research Update Neuropathy: Relief for Diabetics with Painful Conditions

In 2013, we published a research study involving Phase II Hepatocyte Growth Factor (HCF) in Patients with Painful Diabetic Peripheral Neuropathy involving several study groups. The article below is an follow-up to this study which was recently published in Annals of Clinical and Translational Neurology and Science Daily. Neuropathy: Relief for diabetics with painful condition  …

Research Update Neuropathy: Relief for Diabetics with Painful Conditions Read More »

Painful Diabetic Neuropathy

Diabetes is a worldwide epidemic, and associated neuropathy is its most costly and disabling complication. Given the rising prevalence of painful diabetic neuropathy, it is increasingly important that we understand the best ways to diagnose and treat this condition. Diagnostic tests in this field are evolving rapidly. These include the use of skin biopsies to …

Painful Diabetic Neuropathy Read More »